- Home
- SILO
SILO
Silo Pharma Inc.
as of 04-24-2026 3:52pm EST
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | SARASOTA |
| Market Cap: | 7.2M | IPO Year: | 2011 |
| Target Price: | N/A | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | -0.50 | EPS Growth: | 57.98 |
| 52 Week Low/High: | $0.22 - $1.13 | Next Earning Date: | 05-13-2026 |
| Revenue: | $72,102 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 1.86% | Revenue Growth (next year): | N/A |
| P/E Ratio: | -1.00 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Compare SILO vs Leading Stocks
See how SILO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SILO Silo Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.